| 1 |
20926154 | The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis. | 2010 Dec |
3 |
| 2 |
19490202 | Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors. | 2009 Jun |
1 |
| 3 |
16490432 | Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels. | 2006 Mar 1 |
4 |
| 4 |
15959408 | [Arterial wall and glitazones]. | 2005 Apr |
1 |
| 5 |
14693409 | Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects. | 2004 Jan |
2 |
| 6 |
14742804 | Role of C-reactive protein in cardiovascular disease. | 2004 Jan |
1 |
| 7 |
15236798 | AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. | 2004 |
1 |
| 8 |
15459582 | Approach to the management of diabetic patients with heart failure: role of thiazolidinediones. | 2004 Oct |
1 |
| 9 |
12880690 | Pre-diabetes, insulin resistance, inflammation and CVD risk. | 2003 Jul |
1 |